Cargando…
Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway
PURPOSE: Cervical cancer is the fourth most common cancer in women worldwide and is the main cause of cancer-related deaths in women. Cisplatin (DDP) is one of the major chemotherapeutic drugs for cervical cancer patients. But, drug resistance limits the effectiveness of cancer therapy. Nucleolin (N...
Autores principales: | Ke, Jing, Gu, Chunming, Zhang, Heyan, Liu, Yang, Zhang, Wenhao, Rao, Huiling, Li, Shan, Wu, Fuyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084676/ https://www.ncbi.nlm.nih.gov/pubmed/33976698 http://dx.doi.org/10.1155/2021/9992218 |
Ejemplares similares
-
Blockage of Orai1-Nucleolin interaction meditated calcium influx attenuates breast cancer cells growth
por: Gu, Chunming, et al.
Publicado: (2022) -
Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway
por: Wang, Jin-Zhu, et al.
Publicado: (2022) -
YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma
por: Guo, Tao, et al.
Publicado: (2017) -
Nucleolin as Activator of Human Papillomavirus Type 18 Oncogene Transcription in Cervical Cancer
por: Grinstein, Edgar, et al.
Publicado: (2002) -
Correction: YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma
por: Guo, Tao, et al.
Publicado: (2023)